In a webinar on September 23, 2020, FasterCures brought together Peter Marks, director of the US Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research, Gwen Nichols, chief medical officer of the Leukemia & Lymphoma Society, and John Doyle, vice president and global healthcare innovation lead of Pfizer, to discuss the opportunities and challenges of long-term follow-up data collection for cell and gene therapy.
Over the hour-long discussion, the panelists talked about the importance of helping patients understand the value of their data and the need to ensure harmonization in data collection efforts. The panelists agreed on the potential of custom long-term data platforms to help answer outstanding questions about cell and gene therapy. The development of these platforms would be facilitated by a neutral party, such as the FDA or a patient organization, and created with the input of a coalition of interested stakeholders.
The rapid advancement of the health technology landscape relies heavily on patient data. Patient data from medical records and digital health apps can be leveraged to build new tools that can help diagnose disease, remotely monitor and...
Through significant advancements in biomedical innovation, new promising gene and cell therapy treatments may be the key to unlocking the cure to debilitating genetic, oncologic, and other diseases that were once deemed incurable. The first...
The United States—as of June 2020—has more reported cases of COVID-19 than any other country in the world, despite having many of the same resources as other countries that curbed the pandemic more successfully. COVID-19 has highlighted the...
In This Newsletter Program Updates Events and Convenings Recap Recent Publications Policy Updates FasterCures in the Community Upcoming Events Program Updates FasterCures Awarded FDA Funding to Advance Patient Engagement in Medtech...
Esther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives.
In 2022, FasterCures published a report titled The Current Landscape of the Science of Patient Input, which examined the progress of patient engagement (PE) in biomedical research and identified ways to overcome ongoing challenges. Building...
Lauren K. Roth Associate Commissioner for Policy Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Dear Ms. Roth, FasterCures is pleased to respond to the Request for Comments on the FDA Draft Guidance for the...
In This Newsletter New FasterCures Team Members Recent FasterCures Publications Events and Convenings Recap FasterCures in the Community LeadersLink Opportunity New FasterCures Team Members FasterCures is pleased to welcome our two senior...
Esther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives.
In the United States and globally, we are in the golden age of rapid advances in scientific innovation and technology for a wide variety of health challenges. However, health outcomes continue to decline across populations in the US, as...
Esther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives.